A critical breakthrough in cancer research is occurring with the use of VHH fragments to re-engage damaged p53. This essential cancer protector protein is frequently disabled in several types of malignancies, resulting https://mysocialport.com/story7503460/mini-antibodies-reactivate-p53-new-new-hope-for-tumor-treatment